Fumihiko Urabe
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 257 publications
Diet and risk of bladder cancer: a systematic review of epidemiological evidence.
Journal: BJU international
Published: August 24, 2026
Stage-specific prognostic impact and recurrence patterns according to tumor location in upper tract urothelial carcinoma following radical nephroureterectomy: a propensity score-matched analysis.
Journal: Japanese journal of clinical oncology
Published: July 17, 2026
Large-scale Genomic Landscape and Clinical Outcomes of De Novo and Treatment-emergent Neuroendocrine Prostate Cancer.
Journal: European urology open science
Published: June 08, 2026
First-Line Systemic Treatments of Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-Analysis.
Journal: The Journal of urology
Published: May 22, 2026
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapy.
Journal: International journal of clinical oncology
Published: April 29, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).
Journal: ESMO open
Published: April 21, 2026
Efficacy and safety of first-line immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients on hemodialysis.
Journal: Urologic oncology
Published: April 02, 2026
Complete response after enfortumab vedotin plus pembrolizumab for a contralateral ureteral tumor in a solitary kidney after nephroureterectomy.
Journal: International cancer conference journal
Published: March 31, 2026
Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study.
Journal: Urologic oncology
Published: March 30, 2026
Androgen Receptor Pathway Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer Outside of Randomized Controlled Trials: A Systematic Review and Meta-Analysis of Prognostic Factors in Real-World Analyses.
Journal: Clinical genitourinary cancer
Published: March 09, 2026
Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy'.
Journal: Japanese journal of clinical oncology
Published: March 02, 2026
Last Updated: 09/26/2026